Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

NCT00477503 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped One participant enrolled, study terminated .

Conditions

Central Nervous System Tumors
Brain Tumors

Interventions

DRUG: Gallium-67 Citrate (Ga-67)
DRUG: In-111 DTPA (In-111 pentetate)

Sponsor

M.D. Anderson Cancer Center